Nova Leap Health Corp. Announces Results of Annual and Special Meeting of Shareholders
June 28 2023 - 4:15PM
NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”),
announced today that its shareholders voted in favour of all items
of business brought before them at the Company’s annual and special
meeting of shareholders held on June 28, 2023.
At the meeting, the six nominees to the
Company’s Board of Directors, Chris Dobbin, Wayne Myles, Michael
O’Keefe, Dana Hatfield, Marie Mullally and Anne Whelan, were
elected for the ensuing year. Grant Thornton LLP was re-appointed
as the Company’s auditor to hold office until the next annual
meeting of shareholders or until its successor is duly appointed,
at a remuneration to be fixed by the Board.
In addition, the second amended and restated
equity incentive plan of the Company (the “Plan”), which amends and
restates the Company’s existing amended and restated equity
incentive plan, was approved and ratified. The principal amendment
was to change the Plan to a 10% “rolling” plan, allowing for the
issuance of stock options and deferred share units up to a maximum
of 10% of the issued and outstanding common shares of the Company,
and removing the fixed maximum number of common shares that may be
issued upon redemption of deferred share units. More information on
the Plan, including a copy of the Plan, is available in the
Company’s Management Information Circular dated May 30, 2023 filed
on SEDAR.
The voting results for the annual and special
meeting of the shareholders held on June 28, 2023 were as
follows:
MOTIONS |
NUMBER OF SHARES |
PERCENTAGE OF VOTES CAST |
FOR |
AGAINST |
WITHHELD/ ABSTAIN |
SPOILED |
NON VOTE |
FOR |
AGAINST |
WITHHELD/ |
ABSTAIN |
Christopher Dobbin |
40,101,920 |
|
152,560 |
0 |
0 |
0 |
99.62 |
% |
0.38 |
% |
0.00 |
% |
Dana Hatfield |
40,140,920 |
|
113,560 |
0 |
0 |
0 |
99.72 |
% |
0.28 |
% |
0.00 |
% |
Michael O'Keefe |
40,167,980 |
|
86,500 |
0 |
0 |
0 |
99.79 |
% |
0.21 |
% |
0.00 |
% |
Wayne Myles |
40,101,620 |
|
152,860 |
0 |
0 |
0 |
99.62 |
% |
0.38 |
% |
0.00 |
% |
Marie Mullally |
40,046,420 |
|
208,060 |
0 |
0 |
0 |
99.48 |
% |
0.52 |
% |
0.00 |
% |
Anne Whelan |
40,046,420 |
|
208,060 |
0 |
0 |
0 |
99.48 |
% |
0.52 |
% |
0.00 |
% |
Appointment of Auditors |
40,193,980 |
|
- |
60,500 |
0 |
0 |
99.85 |
% |
0.00 |
% |
0.15 |
% |
Approval of Second Amended and Restated Equity Incentive Plan |
39,980,170 |
|
274,310 |
0 |
0 |
0 |
99.32 |
% |
0.68 |
% |
0.00 |
% |
TOTAL SHAREHOLDERS
VOTED BY
PROXY: |
64 |
TOTAL SHARES ISSUED &
OUTSTANDING: |
86,209,252 |
TOTAL SHARES VOTED: |
40,254,480 |
TOTAL % OF SHARES VOTED: |
46.69% |
About Nova Leap
Nova Leap is an acquisitive home health care
services company operating in one of the fastest-growing industries
in the U.S. & Canada. The Company performs a vital role within
the continuum of care with an individual and family centered focus,
particularly those requiring dementia care. Nova Leap achieved the
#42 ranking on the 2021 Report on Business ranking of Canada’s Top
Growing Companies, the #2 ranking on the 2020 Report on Business
ranking of Canada’s Top Growing Companies and the #10 Ranking in
the 2019 TSX Venture 50™ in the Clean Technology & Life
Sciences sector. The Company is geographically diversified with
operations in 10 different U.S. states within the New England,
Southeastern, South Central and Midwest regions as well as in Nova
Scotia, Canada.
CAUTIONARY STATEMENT:
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
For further information:
Chris Dobbin, CPA, ICD.D
Director, President and CEO
T: 902 401 9480
E:cdobbin@novaleaphealth.com
Nova Leap Health (TSXV:NLH)
Historical Stock Chart
From Nov 2024 to Dec 2024
Nova Leap Health (TSXV:NLH)
Historical Stock Chart
From Dec 2023 to Dec 2024